CROI 2017 Program and Information

Program and Agenda

960 DOES HIV TREATMENT AVAILABILITY ENCOURAGE PEOPLE TO LEARN THEIR HIV STATUS? Ellen Moscoe 1 , Jacob Bor 2 , Frank Tanser 3 , Deenan Pillay 4 , Till Baernighausen 5 1 Harvard Univ, Boston, MA, USA, 2 Boston Univ, Boston, MA, USA, 3 Africa Cntr for Pop Hlth, Mtubatuba, South Africa, 4 Africa Hlth Rsr Inst, Mtubatuba, South Africa, 5 Heidelberg Univ, Heidelberg, Germany Poster P-W2 INTERVENTIONS TO IMPROVE THE CARE CASCADE Poster Hall - 4 EF 2:30 PM - 4:00 PM 997 HIV TESTING, LINKAGE TO CARE, ANDVIRAL SUPPRESSION AMONG GAYMEN INNIGERIA Habib R. Omari 1 , Uchenna Ononaku 2 , Rebecca G. Nowak 1 , Ifeanyi Orazulike 3 , Trevor Crowell 4 , Nicaise Ndembi 2 , Hongjie Liu 5 , Stefan Baral 6 , Man Charurat 1 1 Univ of Maryland, Baltimore, MD, USA, 2 Inst of Human Virology Nigeria, Abuja, Nigeria, 3 Intl Cntr on Advocacy and Rights to Hlth, Abuja, Nigeria, 4 US Military HIV Rsr Prog, Bethesda, MD, USA, 5 Univ of Maryland Coll Park, Coll Park, MD, USA, 6 The Johns Hopkins Univ, Baltimore, MD, USA 998 ART INITIATION AND RETENTION IN AFTER-HOUR VERSUS DAILY MALE HEALTH CLINICS Tali Cassidy 1 , Amir Shroufi 1 , Sarah Jane Steele 1 , Morna Cornell 2 , Virginia de Azevedo 3 , David Binza 4 , Rodd Gerstenhaber 1 1 Médecins Sans Frontières, Cape Town, South Africa, 2 Univ of Cape Town, Cape Town, South Africa, 3 City of Cape Town Dept of Hlth, Cape Town, South Africa, 4 Western Cape Provincial Dept of Hlth, Cape Town, South Africa 999 THE IMPACT OF CARE NAVIGATORS ON ENGAGEMENT INHIV CARE INWESTERN KENYA Becky L. Genberg 1 , Violet Naanyu 2 , Alfred Keter 3 , Anthony Ngeresa 3 , Juddy Wachira 2 , Joseph Hogan 4 , Paula Braitstein 4 1 Brown Univ, Providence, RI, USA, 2 Moi Univ, Eldoret, Kenya, 3 Academic Model Providing Access to Hlthcare, Eldoret, Kenya, 4 Univ of Toronto, Toronto, Canada 1000 IMPROVED RETENTIONWITH LONGER FOLLOW-UP INTERVALS FOR STABLE PATIENTS IN ZAMBIA Aaloke Mody 1 , Nancy Padian 2 , Nancy Czaicki 1 , Monika Roy 1 , Carolyn Bolton Moore 3 , Charles Holmes 4 , Elvin Geng 1 , Izukanji Sikazwe 5 1 Univ of California San Francisco, San Francisco, CA, USA, 2 Univ of California Berkeley, Berkeley, CA, USA, 3 Univ of Alabama at Birmingham–CIDRZ, Lusaka, Zambia, 4 The Johns Hopkins Univ–CIDRZ, Bethesda, MD, USA, 5 Cntr for Infectious Disease Rsr in Zambia, Lusaka, Zambia Arvind Kaimal 1 , Barbara Castelnuovo 1 , Martha Atwiine 1 , Rachel Musomba 1 , Maria S. Nabaggala 1 , Rosalind P. Ratanshi 2 , Mohammed Lamorde 1 1 Makerere Univ, Kampala, Uganda, 2 Univ of Cambridge, Cambridge, UK 1002 VIROLOGIC OUTCOMESWHEN ANTIRETROVIRAL THERAPY IS USED FOR PREVENTION: HPTN052 Jessica M. Fogel 1 , Xinyi C. Zhang 2 , Estelle Piwowar-Manning 1 , Nagalingeswaran Kumarasamy 3 , James G. Hakim 4 , Beatriz Grinsztejn 5 , Ying Q. Chen 2 , Myron S. Cohen 6 , Susan H. Eshleman 1 , for the HPTN 052 Study Team 1 The Johns Hopkins Univ Sch of Med, Baltimore, MD, USA, 2 Fred Hutchinson Cancer Rsr Cntr, Seattle, WA, USA, 3 YRG CARE, Chennai, India, 4 Univ of Zimbabwe, Harare, Zimbabwe, 5 Inst de Pesquisa Clinica Evandro Chagas, Rio de Janeiro, Brazil, 6 Univ of North Carolina at Chapel Hill, Chapel Hill, NC, USA 1001 EXPERIENCESWITH RETENTION IN CARE ANDVIRAL SUPPRESION IN A PHARMACY REFILL PROGRAM

Poster Sessions • Tuesday

CROI 2017 117